CoverageForm 410-K10-Q8-K13D13G13F

Sangamo Therapeutics, Inc

SGMOCIK 0001001233 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback
Full filing:tone -0.0002Δ+0.014526% similar+279/-1515

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Sangamo Therapeutics, Inc

NameRolesFilings
Pooler Amy
Officer
5
Carey Robert
Director
4
Hillan Kenneth J.
Director
4
Meyers James R
Director
4
Smith Karen L.
Director
4

Showing 11-15 of 23

PrevPage 3 of 5Next

All filings

175 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue
SGMO · Sangamo Therapeutics, Inc - insider activity · insiderdelta